Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Owlet CFO Scolnick sells shares worth over $11k

Published 20/05/2024, 23:30
OWLT
-

Owlet, Inc. (NYSE:OWLT) Chief Financial Officer Kathryn R. Scolnick has recently sold a portion of her company shares, according to the latest filings. The transactions, which took place on May 10 and May 16, involved the sale of Owlet common stock at weighted average prices ranging from $4.21 to $4.25 per share.

On May 10, Scolnick sold 2,789 shares at an average price of $4.22, totaling approximately $11,769. A few days later, on May 16, an additional 301 shares were sold at an average price of $4.09 per share, amounting to $1,231. The latter transaction was automatically executed to cover taxes and fees related to the vesting of restricted stock units.

Following these transactions, Scolnick's holdings in Owlet decreased, yet she still retains a significant number of shares. Owlet, Inc., headquartered in Lehi, Utah, operates in the field of measuring and controlling devices, providing innovative health monitoring products for infants and caregivers.

Investors typically monitor insider transactions as they can provide insights into executives’ perspectives on their company's stock value. The sales made by CFO Scolnick are part of the regular financial disclosures required by corporate insiders.

InvestingPro Insights

As Owlet, Inc. (NYSE:OWLT) navigates its financial pathway, the recent insider transactions by CFO Kathryn R. Scolnick have caught the attention of investors. With the backdrop of these transactions, it's worth noting some key financial metrics and insights provided by InvestingPro that could shed further light on the company's current standing and future prospects.

One of the notable InvestingPro Data points is Owlet's market capitalization, which currently stands at 35.26 million USD. This valuation reflects the market's assessment of the company's worth as of the latest data. Despite the company's efforts in the innovative health monitoring products space, Owlet has been experiencing a negative revenue growth of -0.5% over the last twelve months, as of Q1 2024. However, there's a silver lining with a quarterly revenue growth of 37.85% in Q1 2024, indicating potential for recovery and expansion.

According to InvestingPro Tips, Owlet is trading at a low revenue valuation multiple, which may appeal to value investors looking for opportunities in the health technology sector. Yet, the company is quickly burning through cash, a situation that requires careful consideration by potential investors. Owlet's stock price movements have also been quite volatile, which could be a factor for those with a lower risk tolerance. Additionally, Owlet does not pay a dividend to shareholders, which might influence the investment decisions of those seeking regular income from their investments.

For those interested in a deeper analysis of Owlet, Inc., there are more InvestingPro Tips available, providing a comprehensive look at the company's financial health and stock performance. Utilize the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro. With this subscription, investors can access a total of 7 insightful tips for Owlet, including expectations on profitability and analysts' perspectives.

These insights, combined with the latest insider transactions, could help investors make more informed decisions regarding their interest in Owlet, Inc.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.